Tenax Therapeutics (TENX) Change in Account Payables (2024 - 2026)
Tenax Therapeutics (TENX) reported Change in Account Payables of $305000.0 for Q1 2026, up 123.14% on a YoY basis from $136684.8 in Q1 2025, and down 29.4% sequentially from $432000.0 in Q4 2025.
Tenax Therapeutics (TENX) Change in Account Payables (2024 - 2026) Analysis & Trends
Tenax Therapeutics (TENX) has 3 years of Change in Account Payables data on file, last reported at $305000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 123.14% year-over-year to $305000.0; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (up 505.78% YoY), and the FY2025 full-year result was $2.9 million, up 171.56% from the prior year.
- Change in Account Payables eased to $305000.0 in Q1 2026, from $432000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $5.0 million in Q3 2025 to a low of -$1.3 million in Q1 2025.
- A 3-year average of $472333.3 and a median of $305000.0 in 2026 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 612.85% in 2025, while the deepest fall reached 477.83% in 2025.
- Tracing TENX's Change in Account Payables over 3 years: stood at $1.6 million in 2024, then plunged by 72.57% to $432000.0 in 2025, then decreased by 29.4% to $305000.0 in 2026.
- Business Quant data shows TENX's Change in Account Payables at $305000.0 in Q1 2026, $432000.0 in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | 305,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 305,000.00 |
| Mar 31, 2026 | 305,000.00 |
| Dec 31, 2025 | 432,000.00 |
| Dec 31, 2025 | 432,000.00 |
| Sep 30, 2025 | 5.05 Mn |
| Sep 30, 2025 | 5.05 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Jun 30, 2025 | -1.28 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Sep 30, 2024 | 708,000.00 |
| Sep 30, 2024 | 708,000.00 |
| Jun 30, 2024 | -221,000.00 |
| Jun 30, 2024 | -221,000.00 |
| Mar 31, 2024 | -1.00 Mn |
| Mar 31, 2024 | -1.00 Mn |